Lebwohl, M., Stein Gold, L., Gooderham, M., Papp, K., Ferris, L., Adam, D., Hong, H. C.- ho, Kircik, L., Zirwas, M., Burnett, P., Higham, R., Krupa, D., & Berk, D. (2023). Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial. SKIN The Journal of Cutaneous Medicine, 7(2), s111. https://doi.org/10.25251/skin.7.supp.111